Bulletin
Investor Alert

New York Markets Open in:

June 23, 2020, 10:11 a.m. EDT

Bullish US Stocks Surging Above Parabolic SAR: $ABBV $ABT $FIS

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    AbbVie Inc. (ABBV)
  • X
    Abbott Laboratories (ABT)
  • X
    Fidelity National Information Services Inc. (FIS)

or Cancel Already have a watchlist? Log In

Jun 23, 2020 (The Market Signal via Comtex) -- The Market Signal was created as a platform to help investors find the best free Stock Reports on stocks they own. If you are a shareholder or looking for stocks to buy /zigman2/quotes/202428675/composite ABBV -0.17% , /zigman2/quotes/203724446/composite ABT +0.91% or /zigman2/quotes/207166559/composite FIS +0.09% then we strongly urge you to join our community by signing up with the link below and getting a completely free research report on each company today.

https://themarketsignal.com/ Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Abbvie Inc.'s Allergan unit's application for Botox use in children with neuro overactivity accepted by FDA

https://themarketsignal.com/Free-Report/ABBV

(Click link above or copy, paste and hit enter in your browser for your report)

Abbvie Inc. /zigman2/quotes/202428675/composite ABBV -0.17% is trading above its Parabolic SAR of $90.92, thus the stock looks bullish. On Monday, the Allergan unit's application for expanding Botox use in children was accepted by the U.S. Food and Drug Administration. The application is being submitted to the FDA for Botox use among children suffering from neurogenic detrusor overactivity.

According to Allergan, this application includes treating the symptoms and signs of detrusor, overactivity or bladder muscle related to the underlying neurologic condition like injuries from spinal cord or spina bifida in patients in age group 5-17 years. The use of Botox is suggested in those patients who have failed to respond adequately to anticholinergic medication.

The decision of FDA regarding this application is expected in Q1-2021, followed by a 10-month review, which is standard procedure.

Abbott Laboratories under FDA radar after false negative COVID-19 test results

https://themarketsignal.com/Free-Report/ABT

(Click link above or copy, paste and hit enter in your browser for your report)

Abbott Laboratories /zigman2/quotes/203724446/composite ABT +0.91% is appearing bullish even as it comes under radar of FDA for ailed test results for COVID-19. The stock is trading above its Parabolic SAR of $87.05. The company, which until now has been praised extensively, even by the White House, is now under FDA's lens that says that the COVID-19 lab test of company may not produce exact results.

The agency has given a warning to company after receiving 15 adverse test reports in which the tests suggested infected patients that they were negative for the infection. This has caused deaths of tens o thousands of patients. The false negative report of company has caused adverse effect on the company as well.

Fidelity national information services paid $14 million for Downtown Jacksonville planned headquarters

https://themarketsignal.com/Free-Report/FIS

(Click link above or copy, paste and hit enter in your browser for your report)

Fidelity National Information Services , /zigman2/quotes/207166559/composite FIS +0.09% global financial technology firm is indicating bullish divergence as the stock is trading above its Parabolic SAR of $13.27. The company paid an amount of $14 million for the Downtown Jacksonville planned headquarters' riverfront site recently.

Duval County Clerk of Courts has a recorded deed for the same on June 12. The firm bought 41/2-acre of Brooklyn site on June 10 at323 Riverside Avenue from Blue Cross Blue Shield, Florida Inc.

Please email orcontact usfor any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

The post Bullish US Stocks Surging Above Parabolic SAR: $ABBV $ABT $FIS appeared first on The Market Signals .

COMTEX_367268902/2662/2020-06-23T10:10:49

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/202428675/composite
US : U.S.: NYSE
$ 89.63
-0.15 -0.17%
Volume: 5.60M
Sept. 17, 2020 4:03p
P/E Ratio
19.07
Dividend Yield
5.27%
Market Cap
$158.45 billion
Rev. per Employee
$1.09M
loading...
/zigman2/quotes/203724446/composite
US : U.S.: NYSE
$ 106.66
+0.96 +0.91%
Volume: 4.28M
Sept. 17, 2020 4:02p
P/E Ratio
61.47
Dividend Yield
1.35%
Market Cap
$187.15 billion
Rev. per Employee
$296,874
loading...
/zigman2/quotes/207166559/composite
US : U.S.: NYSE
$ 148.81
+0.14 +0.09%
Volume: 2.91M
Sept. 17, 2020 4:03p
P/E Ratio
1,635
Dividend Yield
0.94%
Market Cap
$92.12 billion
Rev. per Employee
$179,213
loading...
/zigman2/quotes/202428675/composite
US : U.S.: NYSE
$ 89.63
-0.15 -0.17%
Volume: 5.60M
Sept. 17, 2020 4:03p
P/E Ratio
19.07
Dividend Yield
5.27%
Market Cap
$158.45 billion
Rev. per Employee
$1.09M
loading...
/zigman2/quotes/203724446/composite
US : U.S.: NYSE
$ 106.66
+0.96 +0.91%
Volume: 4.28M
Sept. 17, 2020 4:02p
P/E Ratio
61.47
Dividend Yield
1.35%
Market Cap
$187.15 billion
Rev. per Employee
$296,874
loading...
/zigman2/quotes/207166559/composite
US : U.S.: NYSE
$ 148.81
+0.14 +0.09%
Volume: 2.91M
Sept. 17, 2020 4:03p
P/E Ratio
1,635
Dividend Yield
0.94%
Market Cap
$92.12 billion
Rev. per Employee
$179,213
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.